MKNK1 antisense RNA 1 (MKNK1-AS1)

MKNK1 antisense RNA 1 (MKNK1-AS1) is a long non-coding RNA transcribed in the antisense direction relative to the MKNK1 gene and is identified as an autophagy-associated lncRNA. It serves as an adverse prognostic factor in prostate cancer, where higher expression levels are associated with poorer survival. MKNK1-AS1, along with other lncRNAs, is proposed as a part of a signature for cancer prognosis and may function in gene regulation and autophagy, although its exact molecular mechanism has yet to be precisely defined. MKNK1-AS1 is not a classic protein-coding therapeutic target but represents a potential RNA-based intervention point in cancer and other diseases where autophagy or gene regulation via lncRNAs is disrupted[5]. No evidence is present that it is misspelled or fundamentally misclassified, although knowledge of lncRNA functional mechanisms remains limited and further research is needed to clarify direct therapeutic utility.

Other names

MKNK1-AS1MKNK1 antisense RNA 1 (non-protein coding)MKNK1 antisense RNA 1

Acts as an autophagy-associated lncRNA, influencing cancer cell survival[5] May regulate gene expression post-transcriptionally, typically by acting as a molecular sponge for microRNAs or interacting with chromatin or gene promoters (mechanism is yet to be functionally fully defined for MKNK1-AS1 specifically)